Aptar Pharma, part of the AptarGroup, is a leading name in the pharmaceutical industry, offering comprehensive drug delivery solutions, services, and proprietary technologies. With a focus on patient safety, compliance, and treatment effectiveness, the company serves a broad range of therapeutic areas and markets, including prescription, consumer health care, and injectables.

Aptar Pharma works closely with pharmaceutical partners to bring safe, effective, and user-friendly treatments to market. The company has expertise in device development, formulation support, regulatory affairs, and manufacturing. With an emphasis on innovation and sustainability, Aptar Pharma helps partners navigate complex development paths, providing end-to-end support from early-stage development through to commercial production.

Key Products and Services:

Nasal drug delivery systems: Preservative-free and multi-dose spray pumps for systemic and local treatments

Pulmonary drug delivery devices: Metered dose inhalers (MDIs) and dry powder inhalers (DPIs) for respiratory conditions

Injectable component solutions: Premium elastomeric closures and prefilled syringe components

Dermal and transdermal solutions: Airless dispensing and metering pumps for topical applications

Eye care delivery systems: Preservative-free multi-dose delivery for ophthalmic drugs

Digital health technologies: Connected devices and apps to support adherence and monitor usage

Analytical, development, and regulatory services: End-to-end support including design, testing, and compliance

Manufacturing services: Clinical and commercial fill-finish, especially for complex and high-potency drug products

Aptar Pharma continues to invest in advancing its technology platforms, expanding global manufacturing capabilities, and integrating value-added services to help customers improve patient outcomes and accelerate time to market.